Author: Andy Polk

Shares of The Finish Line rose 63 cents, or 6.5 percent, to $10.37 on Wednesday after Susquehanna Financial Group LLLP analyst Sam Poser wrote in a note that Finish Line’s adoption of a poison pill will likely lead to an acquisition by Sports Direct....